European Heart Journal - Cardiovascular Pharmacotherapy

译名:欧洲心脏杂志-心血管药物治疗

European Heart Journal-Cardiovascular Pharmacotherapy

SCIEJCR Q1中科院1区

5-10

2026

影响因子区间

80天

平台估算

投稿周期

7%

2025

中国作者发文占比

2433 GBP

费用说明

收费

期刊简介:The European Heart Journal - Cardiovascular Pharmacotherapy is a new, international journal published on behalf of the European Society of Cardiology and the Working Group on Cardiovascular Pharmacotherapy. The Journal is freely available until December 2016.This Journal aims to publish the highest quality research, interpreting and integrating new scientific developments within the field of cardiovascular pharmacotherapy. The overarching goal of the Journal is to improve the care of patients with cardiovascular disease with a specific focus on cardiovascular pharmacotherapy.

【译文】《欧洲心脏杂志-心血管药物治疗》是一本由欧洲心脏病学会和心血管药物治疗工作组代表出版的新国际期刊。该期刊免费提供至2016年12月。该期刊旨在发表最高质量的研究,解释和整合心血管药物治疗领域的新科学发展。该期刊的总体目标是提高心血管疾病患者的护理水平,特别关注心血管药物治疗。

出版社
Oxford University Press
语言
English
学科
医学
ISSN
2055-6837
eISSN
2055-6845
出版频率
8期/年
创刊年份
1979
投稿网址
https://www.editorialmanager.com/ehj-cvp
最近更新
2026-04-02 18:16:40
European Heart Journal - Cardiovascular Pharmacotherapy

指标当前值近三年趋势
JCR分区Q1
暂无
中科院分区1区
暂无
影响因子区间5-10
暂无